fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Report of the Bayer satellite symposium EAHP 2013

Written by | 3 Aug 2012

by Christine Clark – The Bayer satellite symposium, ‘The new oral anticoagulants: mechanisms, evidence and day-to-day decisions’, was held at the European Association of Hospital Pharmacists Congress in… read more.

Pazopanib prolongs progression-free survival in patients with advanced soft-tissue Sarcoma

Written by | 31 Jul 2012

by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Treatment with pazopanib nearly tripled progression-free survival (PFS), compared with placebo, among patients with metastatic soft-tissue sarcoma… read more.

ILTS 2012 Report – Experts discuss balancing the risks with the benefits in liver transplantation

Written by | 28 Jun 2012

by Thomas R. Collins – With a scarcity of livers available for transplantation, there is a tremendous pressure on the medical community to make the best use of… read more.

ILTS 2012 Report – Living donor transplant may work well as first-line choice for infants with biliary atresia

Written by | 28 Jun 2012

by Thomas R. Collins –  A living donor liver transplant can be a safe and effective first-line treatment for very young children with biliary atresia,

How the donors have changed in the last ten years

Written by | 28 Jun 2012

Dr Irene Scalera, Fellow at the Liver Unit at Queen Elizabeth Hospital, Birmingham, describes the ever-changing donor landscape and attempts to improve liver donor shortage.

Youth with Type 2 Diabetes get better results with two-drug treatment

Written by | 14 Jun 2012

by Bruce Sylvester – Combination metformin and rosiglitazone is more effective than metformin monotherapy in youth with recent-onset type 2 diabetes,

Green light for new medicines

Written by | 14 Jun 2012

Emerging uses of EMA Approved Drugs – by Gary Finnegan – Several new medicines have been approved by the European Medicines Agency after recent meetings of its Committee… read more.

What’s new in lung transplantation

Written by | 28 Mar 2012

by Professor John Dark (pictured) – In contrast with that other thoracic organ the heart, activity and optimism in the pulmonary field are both increasing. Contemporay outcomes for… read more.

BTS 2012 – The Medawar Medal

Written by | 28 Mar 2012

Now in its twenty-first year, the Medawar Medal continues to reward excellence and innovation among young scientists and doctors in honour of Sir Peter Medawar, Nobel Laureate and… read more.

BTS 2012 Report – Pathways of MHC Allorecognition

Written by | 28 Mar 2012

by Maria Dalby reporting on the presentation by Robert Lechler, King’s College Hospital, London.  Understanding how a transplant recipient’s immune system recognises the alloantigens that trigger rejection is… read more.

BTS 2012 Report – How risky is too risky? The ethical landscape of Challenging Transplants

Written by | 28 Mar 2012

by Maria Dalby – The Ethics Symposium at this year’s BTS Annual Congress was held in a highly interactive format and dealt with the ethical aspects of particularly… read more.

BTS 2012 Report – How long have I got? Up to date estimates of patient survival

Written by | 28 Mar 2012

by Maria Dalby reporting on the presentation by Dave Collett, Donation Advisory Group, NHS Blood and Transplant.  Patient survival is by far the most important outcome in any… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.